The proceeds of (a) the Term Loans funded on the Closing Date were used by the Borrower or its Subsidiaries on the Closing Date to consummate the applicable Transactions and to pay related costs and expenses, (b) the 2016 Incremental Facilities funded on the Restatement Effected Date will be used by the Borrower and its Subsidiaries on the Restatement Effective Date to consummate the applicable Transactions and to pay related costs and expenses and, to the extent any proceeds remain after such application, for general corporate purposes, including, working capital needs, Permitted Acquisitions, Investments, capital expenditures and other corporate purposes of the Borrower and its Subsidiaries, it being understood that except as otherwise agreed by the Lead Arrangers, proceeds of the 2016 Incremental Facilities shall be credited on the Restatement Effective Date to an account of the Borrower maintained at JPMorgan Chase Bank, N.A. for remittance to the Borrower’s designated hedge counterparty to be exchanged into Euros, which Euro proceeds shall be credited on the Restatement Effective Date to an account of the Buyer maintained at JPMorgan Chase Bank, N.A. for remittance to the Seller on the date of the consummation of the Acquisition, and that such accounts at JPMorgan Chase Bank, N.A. shall be subject to the escrow and release arrangements set forth in the respective Escrow Agreements and Section 4.04 (the “ Escrow ”), (c) Incremental Loans, the Revolving Loans and the Swing Line Loans will be used by the Borrower after the Closing Date, including on or after the Restatement Effective Date, to provide for ongoing working capital requirements of the Borrower and its Subsidiaries and for general corporate purposes, including Permitted Acquisitions, Investments and Restricted Payments hereunder ( provided that, in no event shall any Incremental Loans be used to make a Junior Debt Payment) and (d) the Letters of Credit will be used by the Borrower and its Subsidiaries for general corporate purposes.